FI952144A0 - Ei tyypittävissä olevan Haemphilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle - Google Patents
Ei tyypittävissä olevan Haemphilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalleInfo
- Publication number
- FI952144A0 FI952144A0 FI952144A FI952144A FI952144A0 FI 952144 A0 FI952144 A0 FI 952144A0 FI 952144 A FI952144 A FI 952144A FI 952144 A FI952144 A FI 952144A FI 952144 A0 FI952144 A0 FI 952144A0
- Authority
- FI
- Finland
- Prior art keywords
- haemophilus influenzae
- protein
- typable haemophilus
- purified
- vaccine against
- Prior art date
Links
- 241000606768 Haemophilus influenzae Species 0.000 title abstract 3
- 229940047650 haemophilus influenzae Drugs 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 206010061190 Haemophilus infection Diseases 0.000 abstract 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/210,394 US5770213A (en) | 1994-05-05 | 1994-05-05 | Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection |
| US21039494 | 1994-05-05 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI952144A0 true FI952144A0 (fi) | 1995-05-04 |
| FI952144A FI952144A (fi) | 1995-11-06 |
| FI120149B FI120149B (fi) | 2009-07-15 |
Family
ID=22782738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI952144A FI120149B (fi) | 1994-05-05 | 1995-05-04 | Ei tyypittävissä olevan Haemophilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5770213A (fi) |
| EP (1) | EP0680765B1 (fi) |
| JP (2) | JP4236215B2 (fi) |
| KR (1) | KR100366482B1 (fi) |
| AT (1) | ATE356633T1 (fi) |
| AU (1) | AU704882B2 (fi) |
| CA (1) | CA2148563C (fi) |
| DE (1) | DE69535422T2 (fi) |
| DK (1) | DK0680765T3 (fi) |
| ES (1) | ES2282992T3 (fi) |
| FI (1) | FI120149B (fi) |
| IL (1) | IL113595A (fi) |
| NO (1) | NO951750L (fi) |
| PT (1) | PT680765E (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002089839A1 (en) * | 2001-05-03 | 2002-11-14 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella catarrhalis |
| US20040126381A1 (en) * | 1996-04-23 | 2004-07-01 | Xin-Xing Gu | Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella |
| GB9812613D0 (en) * | 1998-06-11 | 1998-08-12 | Smithkline Beecham Biolog | Vaccine |
| US6974581B1 (en) * | 1998-12-15 | 2005-12-13 | Aventis Pasteur Limited | Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease |
| GB9904183D0 (en) * | 1999-02-24 | 1999-04-14 | Smithkline Beecham Biolog | Novel compounds |
| US7101989B1 (en) | 1999-07-09 | 2006-09-05 | University Of North Carolina At Chapel Hill | DsrA protein and polynucleotides encoding the same |
| GB0025486D0 (en) * | 2000-10-17 | 2000-11-29 | Smithkline Beecham Biolog | Novel compounds |
| AU2003250673A1 (en) * | 2002-07-24 | 2004-02-09 | Id Biomedical Corporation | Polypeptides of nontypeable haemophilus influenzae |
| EP2425855A1 (en) | 2005-04-08 | 2012-03-07 | Wyeth LLC | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| AU2009294321B2 (en) | 2008-09-17 | 2014-02-13 | Hunter Immunology Pty Ltd | Non-typeable Haemophilus influenzae vaccines and their uses |
| KR102409709B1 (ko) | 2021-11-30 | 2022-06-16 | 박정민 | 케이블 접속장치 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300632A (en) * | 1986-11-18 | 1994-04-05 | Research Foundation Of State University Of New York | Method for purifying an outer membrane protein of Haemophilus influenzae |
| US5098997A (en) * | 1987-12-11 | 1992-03-24 | Praxis Biologics, Inc. | Vaccines for Haemophilus influenzae |
| US5098987A (en) * | 1989-07-13 | 1992-03-24 | The United States Of America As Represented By The Secretary Of The Air Force | Crosslinkable rigid-rod benzobisazole polymer |
| DE69431624T2 (de) | 1993-05-18 | 2003-07-10 | The Ohio State University Research Foundation, Columbus | Impfstoff gegen mittelohrentzündung |
-
1994
- 1994-05-05 US US08/210,394 patent/US5770213A/en not_active Ceased
-
1995
- 1995-05-02 PT PT95302996T patent/PT680765E/pt unknown
- 1995-05-02 ES ES95302996T patent/ES2282992T3/es not_active Expired - Lifetime
- 1995-05-02 AT AT95302996T patent/ATE356633T1/de not_active IP Right Cessation
- 1995-05-02 DE DE69535422T patent/DE69535422T2/de not_active Expired - Lifetime
- 1995-05-02 JP JP13295495A patent/JP4236215B2/ja not_active Expired - Fee Related
- 1995-05-02 DK DK95302996T patent/DK0680765T3/da active
- 1995-05-02 EP EP95302996A patent/EP0680765B1/en not_active Expired - Lifetime
- 1995-05-03 IL IL11359595A patent/IL113595A/en not_active IP Right Cessation
- 1995-05-03 CA CA002148563A patent/CA2148563C/en not_active Expired - Fee Related
- 1995-05-03 AU AU17814/95A patent/AU704882B2/en not_active Ceased
- 1995-05-04 FI FI952144A patent/FI120149B/fi active IP Right Grant
- 1995-05-04 KR KR1019950011163A patent/KR100366482B1/ko not_active IP Right Cessation
- 1995-05-04 NO NO951750A patent/NO951750L/no unknown
-
2000
- 2000-06-21 US US09/599,652 patent/USRE37741E1/en not_active Expired - Lifetime
-
2008
- 2008-10-24 JP JP2008274435A patent/JP2009051859A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2148563A1 (en) | 1995-11-06 |
| IL113595A (en) | 2001-05-20 |
| FI952144A (fi) | 1995-11-06 |
| PT680765E (pt) | 2007-05-31 |
| KR950031108A (ko) | 1995-12-18 |
| US5770213A (en) | 1998-06-23 |
| KR100366482B1 (ko) | 2003-08-02 |
| IL113595A0 (en) | 1995-08-31 |
| EP0680765B1 (en) | 2007-03-14 |
| AU704882B2 (en) | 1999-05-06 |
| DK0680765T3 (da) | 2007-07-02 |
| NO951750L (no) | 1995-11-06 |
| ES2282992T3 (es) | 2007-10-16 |
| JP2009051859A (ja) | 2009-03-12 |
| NO951750D0 (no) | 1995-05-04 |
| USRE37741E1 (en) | 2002-06-11 |
| CA2148563C (en) | 2008-10-07 |
| EP0680765A1 (en) | 1995-11-08 |
| DE69535422T2 (de) | 2007-12-13 |
| JP4236215B2 (ja) | 2009-03-11 |
| FI120149B (fi) | 2009-07-15 |
| ATE356633T1 (de) | 2007-04-15 |
| DE69535422D1 (de) | 2007-04-26 |
| JPH08337598A (ja) | 1996-12-24 |
| AU1781495A (en) | 1995-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6236396A (en) | Omp26 antigen from haemophilus influenzae | |
| WO1998008542A3 (en) | Compounds and methods for treatment and diagnosis of mycobacterial infections | |
| NZ512574A (en) | Novel streptococcus antigens useful as vaccines | |
| WO1999042588A3 (en) | Group b streptococcus antigens | |
| CA2051808A1 (en) | Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same | |
| FI952144A0 (fi) | Ei tyypittävissä olevan Haemphilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle | |
| ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
| DK84083D0 (da) | Fremgangsmade til fremstilling af polysaccharid-protein-komplekser ud fra bakterielle kapsler | |
| AU1915995A (en) | Active immunization using a siderophore receptor protein | |
| ATE120487T1 (de) | Therapeutische zusammensetzungen gegen streptokokken-infektionen, transformierte wirte, verfahren zur immunisierung und gentechnologisch hergestellte produkte. | |
| WO1997005899A3 (en) | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same | |
| DK0565590T3 (da) | Adhesin-oligosaccharid-konjugatvaccine mod Haemophilus influenzae | |
| AU3313789A (en) | Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine | |
| FI960308A0 (fi) | Menetelmä Haemophilus influenzae, tyyppi b:n P2-proteiinien ilmentämiseksi ja puhdistamiseksi | |
| PT95789A (pt) | Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis | |
| EP0090660A3 (en) | Neisseria gonorrhoeae vaccine | |
| AU2548597A (en) | Antibodies against avirulence/pathogenicity proteins of plant pathogens | |
| DK0550683T3 (da) | Vaccine egnet til bekæmpelse af Borderella pertussis | |
| EP0328390A3 (en) | Peptide treatment of refractory infectious diseases | |
| EP1950302A3 (en) | Streptococcus antigens | |
| ATE206619T1 (de) | Komplex aus antigen und zellbestandteil, verfahren zur dessen herstellung und therapeutische verwendungen | |
| BR9601748A (pt) | Desenvolvimento de vacina acelular anti-coqueluche por etapa única de purificaç o de sobrenadante ou filtrado de cultura de bordetella pertussis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 120149 Country of ref document: FI |